VEGF has a hydrophobic signal sequence and exerts a potent mitogenic activity on vascular endothelial cells isolated from both small and large vessels, but does not affect the growth of other types of cells such as fibroblasts, lens epithelial cells, corneal endothelial cells, keratinocytes, or adrenal cortex cells (Ferrara and Henzel 1989 ; Leung et al. 1989) .
Two receptors for VEGF, fit (Shibuya et al. 1990; De Vries et al. 1992 ) and ilk-1 (Matthews et al. 1991; Millauer et al. 1993) , have been identified restrictively on vascular endothelial cells in vivo. Recently, it was demonstrated that an insufficient vascular supply and a resultant reduction in tissue oxygen tension stimulate glioblastoma multiforme, a rapid growing tumor, to secrete VEGF so as to cause angiogenesis (Plate et al. 1992; Shweiki et al. 1992 ). These findings suggest that VEGF is an endothelial cell-specific mitogen and an angiogenesis inducer in normal as well as neoplastic tissues.
Renal cell carcinoma is defined as a rapid growing tumor associated with necrosis and prominent vascularization with endothelial cell proliferation. These characteristics of renal cell carcinoma would be attributable, at least in part, to the function of VEGF which may be secreted by this tumor. In the light of glioblastoma multiforme, we evaluated expression of VEGF gene in the renal cell 
MATERIALS AND METHODS
Tumor and corresponding normal renal tissue specimens were obtained at surgery from 20 consecutive patients with renal cell carcinoma ( Table 1) . A part of each tissue specimen was stored at -80°C for molecular biological study and the remainder was fixed with formaldehyde for routine histological study. White blood cells were obtained from peripheral blood of patients and also subjected to molecular biological study. For preparation of a DNA probe identical to human VEGF gene (Tischer et al. 1991) , 0.4 ,a g of cDNA, synthesized from total RNA extracted from human normal kidney with Moloney murine leukemia virus (MMLV) reverse transcriptase (Gibco BRL, Gaitherburg, MD, USA), was subjected to 35 rounds of amplification by polymerase chain reaction (PCR). Cycles were 5 sec at 94°C, 10 sec at 55°C and 15 sec at 72°C in a thermal cycler (Air Thermo-Cycler, Idaho Technology Co., Ltd., Idahofall, ID, USA). The nucleotide sequence of the primers used in the PCR was as follows; sense strand, 5'-GAGGAGTCCACCATCACCATGCAG-3' (VEGFUP) and antisense strand, 5'-GGCTCACCGCCTCGGCTTGTAACA-3' (VEGFDW). This PCR yielded three sizes of product spanning 156 base pair (bp), 288 by and 360 by of coding region, corresponding to VEGF 121, VEGF 165 and VEGF 189 subunits (Tischer et al. 1991) , respectively. Of the three, a product of 156 by was isolated from an agarose gel, purified and provided as VEGF probe, because DNA sequence of this probe was common in these 3 subunits. Identification of the probe to VEGF gene was confirmed by direct sequencing technique using Sequi-ThermeTM cycle sequencing kit (Epicentre Technologies, Madison, WI, USA) (data not shown). Denatured 10 1u g of total RNAs extracted from frozen tissue samples by guanidium acid phenol method were electrophoretically fractionated on a 0.8% agarose gel and transferred on to a nylon membrane (Gene Screen Plus filter, NEN, London) (Maniatis et al. 1989 ). The membrane was hybridized with 50 ng of 32P-labeled VEGF probe described above (specific activity , at least 108 cpm/ ugDNA), washed and autoradiographed at -80°C (Maniatis et al. 1989 ). As the internal control for signal alignment, a /3-actin probe was used. Photodensitometory was carried out in a comparative approach.
RESULTS AND DISCUSSION
The Northern blot hybridization analysis of the 20 tumor/normal kidney pairs was shown in Table 1 (Table 1) . However, it may be noteworthy that no renal cell carcinomas with cystic subtype have overexpressed the gene.
Our preliminary results has demonstrated the expression of VEGF gene in human renal cell carcinoma, the frequency of overexpression of the gene being as high as 60%. Recently, Brown et al. (1993) investigated expression of VEGF gene in renal cell carcinoma by in situ hybridization and demonstrated that, of the 12 renal cell carcinoma examined, 11(91.7%) expressed higher levels of VEGF gene compared to normal renal tissue (Brown et al. 1993) . Although there was a difference between overexpression rates of the 2 studies, which possibly came from detection method employed and criteria for judgment of overexpression, these studies will indicate that VEGF is frequently overexpressed in renal cell carcinoma and responsible for the development of this hypervascular tumor as it is in the glioblastoma (Plate et al. 1992; Shweiki et al. 1992 ; Kim et al. 1993) .
In a number of specific tumor types, including neoplasms of the bladder (Chodak et al. 1980 ), cervix (Sillman et al. 1981 ) and cutaneous melanoma (Srivastava et al. 1988) , there is a growing body of experimental evidence suggesting that vascularity may be an important prognostic indicator of aggressive behavior. Especially in invasive breast carcinoma, it has been postulated that a degree of angiogenesis correlates well with metastatic ability of the tumor (Weidner et al. 1991). Follow-up study on our patients will clarify whether the degree of VEGF gene expression correlates with the malignant potential of renal cell carcinoma.
